Skip to main content
Equibles

STATE STREET CORP

Position in VRCA — Verrica Pharmaceuticals Inc.

CIK 93751 BOSTON, MA
Back to VRCA Full portfolio

Position in VRCA

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$176,965
+$24,000 QoQ
Shares Held
28,916
0.0% QoQ
Ownership
0.168%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 43 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 64% Shared 0% None 36%

Common Shares in VRCA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STATE STREET CORP holds $36,881,619,425 across 411 Biotechnology names. VRCA ranks #345 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 11,871,459 $5,896,909,829
2 REGN
Regeneron Pharmaceuticals, Inc.
 4,834,688 $3,014,621,355
3 INCY
Incyte Corp
 9,722,336 $1,102,124,008
4 MRNA
Moderna, Inc.
 15,726,193 $1,101,305,295
5 ALNY
Alnylam Pharmaceuticals, Inc.
 3,555,689 $1,070,369,059
6 RVMD
Revolution Medicines, Inc.
 4,897,051 $917,119,711
7 RPRX
Royalty Pharma plc
 12,338,229 $691,804,500
8 INSM
INSMED Inc
 6,052,174 $645,282,791

All Filings in VRCA

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $176,965 28,916
2026-03-31 $152,965 28,916
2025-12-31 $195,127 23,481
2025-09-30 $88,704 20,581
2025-06-30 $48,662 91,816
2025-03-31 $250,635 567,048
2024-12-31 $366,182 523,118
2024-09-30 $743,590 512,821
2024-06-30 $3,293,476 451,780
2024-03-31 $2,442,609 412,603
2023-12-31 $2,849,434 389,267
2023-09-30 $1,486,956 382,743
2023-06-30 $2,170,160 376,111
2023-03-31 $440,154 67,716
2022-12-31 $172,744 62,816
2022-09-30 $183,422 62,816
2022-06-30 $159,006 82,816
2022-03-31 $1,873,693 231,035
2021-12-31 $2,073,970 226,416
2021-09-30 $2,845,575 227,646
2021-06-30 $2,422,121 214,347
2021-03-31 $3,308,002 218,350
2020-12-31 $2,568,778 223,178
2020-09-30 $1,800,145 232,577
2020-06-30 $2,603,809 236,495
2020-03-31 $2,566,374 234,801